Leerink Partners Maintains Acadia Healthcare(ACHC.US) With Buy Rating
Mizuho Securities Maintains Acadia Healthcare(ACHC.US) With Hold Rating, Cuts Target Price to $62
Acadia Healthcare Co Analyst Ratings
Cantor Fitzgerald Reiterates Neutral on Acadia Healthcare Co, Maintains $90 Price Target
Analysts Offer Insights on Healthcare Companies: Acadia Healthcare (ACHC), Aquestive Therapeutics (AQST) and Inspire Medical Systems (INSP)
Leerink Partners Maintains Acadia Healthcare(ACHC.US) With Buy Rating, Maintains Target Price $87
Acadia Healthcare Is Maintained at Overweight by Barclays
Acadia Healthcare Co Analyst Ratings
Jefferies Maintains Acadia Healthcare(ACHC.US) With Buy Rating, Maintains Target Price $105
Barclays Maintains Acadia Healthcare(ACHC.US) With Buy Rating, Maintains Target Price $76
Jefferies Maintains Acadia Healthcare(ACHC.US) With Buy Rating, Maintains Target Price $105
Barclays Maintains Acadia Healthcare(ACHC.US) With Buy Rating, Cuts Target Price to $76
RBC Capital Maintains Acadia Healthcare(ACHC.US) With Buy Rating
Acadia Healthcare Price Target Maintained With a $94.00/Share by RBC Capital
Acadia Healthcare Co Analyst Ratings
RBC Capital Maintains Acadia Healthcare(ACHC.US) With Buy Rating, Maintains Target Price $94
RBC Capital Sticks to Their Buy Rating for Acadia Healthcare (ACHC)
Cantor Fitzgerald Reiterates Neutral on Acadia Healthcare Co, Maintains $90 Price Target
Acadia Healthcare Co Analyst Ratings
Cantor Fitzgerald Reiterates Neutral on Acadia Healthcare Co, Maintains $90 Price Target